Free Trial

Stevanato Group (NYSE:STVN) Hits New 52-Week High - Time to Buy?

Stevanato Group logo with Medical background

Shares of Stevanato Group S.p.A. (NYSE:STVN - Get Free Report) hit a new 52-week high during trading on Thursday . The company traded as high as €25.88 ($30.45) and last traded at €25.76 ($30.31), with a volume of 105974 shares trading hands. The stock had previously closed at €25.25 ($29.71).

Analyst Ratings Changes

STVN has been the subject of a number of research reports. UBS Group decreased their target price on Stevanato Group from $24.00 to $23.50 and set a "neutral" rating for the company in a research note on Friday, March 7th. William Blair restated an "outperform" rating on shares of Stevanato Group in a research note on Friday, March 7th. Finally, Stephens upgraded Stevanato Group to a "strong-buy" rating in a research note on Monday, April 21st. Two research analysts have rated the stock with a hold rating, four have assigned a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, Stevanato Group has an average rating of "Moderate Buy" and a consensus price target of €25.70 ($30.24).

Check Out Our Latest Research Report on STVN

Stevanato Group Stock Performance

The company has a quick ratio of 1.26, a current ratio of 1.83 and a debt-to-equity ratio of 0.22. The company has a 50-day moving average price of €23.02 and a 200-day moving average price of €21.89. The firm has a market capitalization of $7.47 billion, a price-to-earnings ratio of 45.63, a P/E/G ratio of 2.35 and a beta of 0.53.

Stevanato Group Increases Dividend

The firm also recently disclosed an annual dividend, which will be paid on Thursday, July 17th. Stockholders of record on Thursday, June 5th will be given a dividend of $0.0613 per share. The ex-dividend date of this dividend is Thursday, June 5th. This is an increase from Stevanato Group's previous annual dividend of $0.05. This represents a dividend yield of 0.3%.

Hedge Funds Weigh In On Stevanato Group

Hedge funds and other institutional investors have recently made changes to their positions in the business. M&T Bank Corp acquired a new position in shares of Stevanato Group during the fourth quarter worth approximately $572,000. D. E. Shaw & Co. Inc. bought a new stake in Stevanato Group during the fourth quarter worth approximately $281,000. Mutual of America Capital Management LLC bought a new stake in Stevanato Group during the fourth quarter worth approximately $13,848,000. Advantage Alpha Capital Partners LP raised its holdings in Stevanato Group by 27.3% during the fourth quarter. Advantage Alpha Capital Partners LP now owns 293,865 shares of the company's stock worth $6,403,000 after purchasing an additional 63,041 shares in the last quarter. Finally, Allianz SE bought a new stake in Stevanato Group during the fourth quarter worth approximately $748,000.

About Stevanato Group

(Get Free Report)

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.

See Also

Should You Invest $1,000 in Stevanato Group Right Now?

Before you consider Stevanato Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Stevanato Group wasn't on the list.

While Stevanato Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Time to Cash Out? 5 Stocks to Drop Before Earnings
Watch Before Monday: Stocks to Load Up on Before Earnings
3 Hot Growth Stocks to Watch Right Now!

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines